Reduction of flurazepam convulsive threshold by Ro 15-1788

• Published in: Psychopharmacologia 1985-01, Vol.85 (3), p.267-270
• Main Authors: BOURN, W. M, GARRETT, R. L, REIGEL, C. E, RISINGER, F. O
• Format: Article
• Language: English
• Subjects: Animals; Benzodiazepinones - pharmacology; Biological and medical sciences; Convulsants - antagonists & inhibitors; Electric Stimulation; Electroencephalography; Flumazenil; Flurazepam - antagonists & inhibitors; Male; Medical sciences; Neuropharmacology; Pharmacology. Drug treatments; Psycholeptics: tranquillizer, neuroleptic; Psychology. Psychoanalysis. Psychiatry; Psychopharmacology; Rats; Rats, Inbred Strains; Respiration - drug effects; Seizures - physiopathology; Time Factors
• ISSN: 0033-3158; 1432-2072
• DOI: 10.1007/BF00428185

The influence of the benzodiazepine (BZ) receptor antagonist Ro 15-1788 on the convulsant properties of flurazepam (FLZ) was studied in rats. Animals were prepared with chronic epidural electrodes for EEG recording and respiratory rates were recorded via a rubber bulb connected to a pressure transducer. FLZ convulsive thresholds were determined by continuous IV infusion in the presence and absence of Ro 15-1788 pretreatment. All animals receiving the FLZ infusion experienced convulsions preceded by dose-dependent reduction of respiratory rate. Pretreatment with Ro 15-1788 substantially reduced the FLZ convulsive threshold, suggesting a blockade of the depressant (anticonvulsant) aspect of the FLZ effect, thus, augmenting a convulsant effect at a separate receptor. An alternate hypothesis is that Ro 15-1788 may increase the affinity or intrinsic activity of the receptor responsible for the convulsant aspect of FLZ. Ro 15-1788 did not appear to alter the respiratory rate depressant effect of FLZ, although early onset of convulsions in the pretreated animals precluded measurement of respiration at the higher dose of FLZ allowable in animals that were not pretreated with the antagonist.